0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Inhaler Corticosteroid Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-19D14675
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Inhaler Corticosteroid Device Market Research Report 2023
BUY CHAPTERS

Inhaler Corticosteroid Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19D14675
Report
October 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhaler Corticosteroid Device - Market Size

The global market for Inhaler Corticosteroid Device was estimated to be worth US$ 594 million in 2023 and is forecast to a readjusted size of US$ 831.5 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Inhaler Corticosteroid Device - Market

Inhaler Corticosteroid Device - Market

North American market for Inhaler Corticosteroid Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inhaler Corticosteroid Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Inhaler Corticosteroid Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Inhaler Corticosteroid Device include Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd. and Amgen Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaler Corticosteroid Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhaler Corticosteroid Device by region & country, by Type, and by Application.
The Inhaler Corticosteroid Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Corticosteroid Device.
Market Segmentation

Scope of Inhaler Corticosteroid Device - Market Report

Report Metric Details
Report Name Inhaler Corticosteroid Device - Market
Forecasted market size in 2030 US$ 831.5 million
CAGR 4.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Beclomethasone Dipropionate
  • Budesonide
  • Fluticasone Inhaler Powder
  • Mometasone
Segment by Application
  • Hospitals and Clinics
  • Academic and Research Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, Sumitomo Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Inhaler Corticosteroid Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Inhaler Corticosteroid Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Inhaler Corticosteroid Device in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Inhaler Corticosteroid Device - Market size in 2030?

Ans: The Inhaler Corticosteroid Device - Market size in 2030 will be US$ 831.5 million.

Who are the main players in the Inhaler Corticosteroid Device - Market report?

Ans: The main players in the Inhaler Corticosteroid Device - Market are Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, Sumitomo Corporation

What are the Application segmentation covered in the Inhaler Corticosteroid Device - Market report?

Ans: The Applications covered in the Inhaler Corticosteroid Device - Market report are Hospitals and Clinics, Academic and Research Institutes

What are the Type segmentation covered in the Inhaler Corticosteroid Device - Market report?

Ans: The Types covered in the Inhaler Corticosteroid Device - Market report are Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, Mometasone

1 Market Overview
1.1 Inhaler Corticosteroid Device Product Introduction
1.2 Global Inhaler Corticosteroid Device Market Size Forecast
1.2.1 Global Inhaler Corticosteroid Device Sales Value (2019-2030)
1.2.2 Global Inhaler Corticosteroid Device Sales Volume (2019-2030)
1.2.3 Global Inhaler Corticosteroid Device Sales Price (2019-2030)
1.3 Inhaler Corticosteroid Device Market Trends & Drivers
1.3.1 Inhaler Corticosteroid Device Industry Trends
1.3.2 Inhaler Corticosteroid Device Market Drivers & Opportunity
1.3.3 Inhaler Corticosteroid Device Market Challenges
1.3.4 Inhaler Corticosteroid Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Inhaler Corticosteroid Device Players Revenue Ranking (2023)
2.2 Global Inhaler Corticosteroid Device Revenue by Company (2019-2024)
2.3 Global Inhaler Corticosteroid Device Players Sales Volume Ranking (2023)
2.4 Global Inhaler Corticosteroid Device Sales Volume by Company Players (2019-2024)
2.5 Global Inhaler Corticosteroid Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Inhaler Corticosteroid Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Inhaler Corticosteroid Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Inhaler Corticosteroid Device
2.9 Inhaler Corticosteroid Device Market Competitive Analysis
2.9.1 Inhaler Corticosteroid Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Inhaler Corticosteroid Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaler Corticosteroid Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Beclomethasone Dipropionate
3.1.2 Budesonide
3.1.3 Fluticasone Inhaler Powder
3.1.4 Mometasone
3.2 Global Inhaler Corticosteroid Device Sales Value by Type
3.2.1 Global Inhaler Corticosteroid Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Inhaler Corticosteroid Device Sales Value, by Type (2019-2030)
3.2.3 Global Inhaler Corticosteroid Device Sales Value, by Type (%) (2019-2030)
3.3 Global Inhaler Corticosteroid Device Sales Volume by Type
3.3.1 Global Inhaler Corticosteroid Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Inhaler Corticosteroid Device Sales Volume, by Type (2019-2030)
3.3.3 Global Inhaler Corticosteroid Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Inhaler Corticosteroid Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Academic and Research Institutes
4.2 Global Inhaler Corticosteroid Device Sales Value by Application
4.2.1 Global Inhaler Corticosteroid Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Inhaler Corticosteroid Device Sales Value, by Application (2019-2030)
4.2.3 Global Inhaler Corticosteroid Device Sales Value, by Application (%) (2019-2030)
4.3 Global Inhaler Corticosteroid Device Sales Volume by Application
4.3.1 Global Inhaler Corticosteroid Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Inhaler Corticosteroid Device Sales Volume, by Application (2019-2030)
4.3.3 Global Inhaler Corticosteroid Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Inhaler Corticosteroid Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Inhaler Corticosteroid Device Sales Value by Region
5.1.1 Global Inhaler Corticosteroid Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Inhaler Corticosteroid Device Sales Value by Region (2019-2024)
5.1.3 Global Inhaler Corticosteroid Device Sales Value by Region (2025-2030)
5.1.4 Global Inhaler Corticosteroid Device Sales Value by Region (%), (2019-2030)
5.2 Global Inhaler Corticosteroid Device Sales Volume by Region
5.2.1 Global Inhaler Corticosteroid Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Inhaler Corticosteroid Device Sales Volume by Region (2019-2024)
5.2.3 Global Inhaler Corticosteroid Device Sales Volume by Region (2025-2030)
5.2.4 Global Inhaler Corticosteroid Device Sales Volume by Region (%), (2019-2030)
5.3 Global Inhaler Corticosteroid Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Inhaler Corticosteroid Device Sales Value, 2019-2030
5.4.2 North America Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Inhaler Corticosteroid Device Sales Value, 2019-2030
5.5.2 Europe Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Inhaler Corticosteroid Device Sales Value, 2019-2030
5.6.2 Asia Pacific Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Inhaler Corticosteroid Device Sales Value, 2019-2030
5.7.2 South America Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Inhaler Corticosteroid Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Inhaler Corticosteroid Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Inhaler Corticosteroid Device Sales Value
6.2.1 Key Countries/Regions Inhaler Corticosteroid Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Inhaler Corticosteroid Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Inhaler Corticosteroid Device Sales Value, 2019-2030
6.3.2 United States Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Inhaler Corticosteroid Device Sales Value, 2019-2030
6.4.2 Europe Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Inhaler Corticosteroid Device Sales Value, 2019-2030
6.5.2 China Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Inhaler Corticosteroid Device Sales Value, 2019-2030
6.6.2 Japan Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Inhaler Corticosteroid Device Sales Value, 2019-2030
6.7.2 South Korea Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Inhaler Corticosteroid Device Sales Value, 2019-2030
6.8.2 Southeast Asia Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Inhaler Corticosteroid Device Sales Value, 2019-2030
6.9.2 India Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Inhaler Corticosteroid Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Information
7.1.2 Pfizer Inc. Introduction and Business Overview
7.1.3 Pfizer Inc. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Inc. Inhaler Corticosteroid Device Product Offerings
7.1.5 Pfizer Inc. Recent Development
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Company Information
7.2.2 GlaxoSmithKline Plc Introduction and Business Overview
7.2.3 GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GlaxoSmithKline Plc Inhaler Corticosteroid Device Product Offerings
7.2.5 GlaxoSmithKline Plc Recent Development
7.3 Novartis AG
7.3.1 Novartis AG Company Information
7.3.2 Novartis AG Introduction and Business Overview
7.3.3 Novartis AG Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novartis AG Inhaler Corticosteroid Device Product Offerings
7.3.5 Novartis AG Recent Development
7.4 Mylan NV
7.4.1 Mylan NV Company Information
7.4.2 Mylan NV Introduction and Business Overview
7.4.3 Mylan NV Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Mylan NV Inhaler Corticosteroid Device Product Offerings
7.4.5 Mylan NV Recent Development
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Teva Pharmaceutical Industries Ltd. Company Information
7.5.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.5.3 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product Offerings
7.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.6 Boehringer Ingelheim International GmbH
7.6.1 Boehringer Ingelheim International GmbH Company Information
7.6.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
7.6.3 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product Offerings
7.6.5 Boehringer Ingelheim International GmbH Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Information
7.7.2 AstraZeneca Introduction and Business Overview
7.7.3 AstraZeneca Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 AstraZeneca Inhaler Corticosteroid Device Product Offerings
7.7.5 AstraZeneca Recent Development
7.8 F. Hoffmann-La Roche Ltd.
7.8.1 F. Hoffmann-La Roche Ltd. Company Information
7.8.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
7.8.3 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product Offerings
7.8.5 F. Hoffmann-La Roche Ltd. Recent Development
7.9 Amgen Inc.
7.9.1 Amgen Inc. Company Information
7.9.2 Amgen Inc. Introduction and Business Overview
7.9.3 Amgen Inc. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Amgen Inc. Inhaler Corticosteroid Device Product Offerings
7.9.5 Amgen Inc. Recent Development
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Company Information
7.10.2 Aurobindo Pharma Introduction and Business Overview
7.10.3 Aurobindo Pharma Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Aurobindo Pharma Inhaler Corticosteroid Device Product Offerings
7.10.5 Aurobindo Pharma Recent Development
7.11 Sumitomo Corporation
7.11.1 Sumitomo Corporation Company Information
7.11.2 Sumitomo Corporation Introduction and Business Overview
7.11.3 Sumitomo Corporation Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Sumitomo Corporation Inhaler Corticosteroid Device Product Offerings
7.11.5 Sumitomo Corporation Recent Development
8 Industry Chain Analysis
8.1 Inhaler Corticosteroid Device Industrial Chain
8.2 Inhaler Corticosteroid Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Inhaler Corticosteroid Device Sales Model
8.5.2 Sales Channel
8.5.3 Inhaler Corticosteroid Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Inhaler Corticosteroid Device Market Trends
    Table 2. Inhaler Corticosteroid Device Market Drivers & Opportunity
    Table 3. Inhaler Corticosteroid Device Market Challenges
    Table 4. Inhaler Corticosteroid Device Market Restraints
    Table 5. Global Inhaler Corticosteroid Device Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Inhaler Corticosteroid Device Revenue Market Share by Company (2019-2024)
    Table 7. Global Inhaler Corticosteroid Device Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Inhaler Corticosteroid Device Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Inhaler Corticosteroid Device Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Inhaler Corticosteroid Device Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Inhaler Corticosteroid Device Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Inhaler Corticosteroid Device
    Table 13. Global Inhaler Corticosteroid Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaler Corticosteroid Device as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Inhaler Corticosteroid Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Inhaler Corticosteroid Device Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Inhaler Corticosteroid Device Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Inhaler Corticosteroid Device Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Inhaler Corticosteroid Device Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Inhaler Corticosteroid Device Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Inhaler Corticosteroid Device Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Inhaler Corticosteroid Device Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Inhaler Corticosteroid Device Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Inhaler Corticosteroid Device Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Inhaler Corticosteroid Device Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Inhaler Corticosteroid Device Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Inhaler Corticosteroid Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Inhaler Corticosteroid Device Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Inhaler Corticosteroid Device Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Inhaler Corticosteroid Device Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Inhaler Corticosteroid Device Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Inhaler Corticosteroid Device Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Inhaler Corticosteroid Device Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Inhaler Corticosteroid Device Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Inhaler Corticosteroid Device Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Inhaler Corticosteroid Device Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Inhaler Corticosteroid Device Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Inhaler Corticosteroid Device Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Inhaler Corticosteroid Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Inhaler Corticosteroid Device Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Inhaler Corticosteroid Device Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Inhaler Corticosteroid Device Sales Value by Region (2019-2024) & (%)
    Table 44. Global Inhaler Corticosteroid Device Sales Value by Region (2025-2030) & (%)
    Table 45. Global Inhaler Corticosteroid Device Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Inhaler Corticosteroid Device Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Inhaler Corticosteroid Device Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Inhaler Corticosteroid Device Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Inhaler Corticosteroid Device Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Inhaler Corticosteroid Device Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Inhaler Corticosteroid Device Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Inhaler Corticosteroid Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Inhaler Corticosteroid Device Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Inhaler Corticosteroid Device Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Inhaler Corticosteroid Device Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Inhaler Corticosteroid Device Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer Inc. Company Information
    Table 58. Pfizer Inc. Introduction and Business Overview
    Table 59. Pfizer Inc. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer Inc. Inhaler Corticosteroid Device Product Offerings
    Table 61. Pfizer Inc. Recent Development
    Table 62. GlaxoSmithKline Plc Company Information
    Table 63. GlaxoSmithKline Plc Introduction and Business Overview
    Table 64. GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. GlaxoSmithKline Plc Inhaler Corticosteroid Device Product Offerings
    Table 66. GlaxoSmithKline Plc Recent Development
    Table 67. Novartis AG Company Information
    Table 68. Novartis AG Introduction and Business Overview
    Table 69. Novartis AG Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Novartis AG Inhaler Corticosteroid Device Product Offerings
    Table 71. Novartis AG Recent Development
    Table 72. Mylan NV Company Information
    Table 73. Mylan NV Introduction and Business Overview
    Table 74. Mylan NV Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Mylan NV Inhaler Corticosteroid Device Product Offerings
    Table 76. Mylan NV Recent Development
    Table 77. Teva Pharmaceutical Industries Ltd. Company Information
    Table 78. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 79. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product Offerings
    Table 81. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 82. Boehringer Ingelheim International GmbH Company Information
    Table 83. Boehringer Ingelheim International GmbH Introduction and Business Overview
    Table 84. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product Offerings
    Table 86. Boehringer Ingelheim International GmbH Recent Development
    Table 87. AstraZeneca Company Information
    Table 88. AstraZeneca Introduction and Business Overview
    Table 89. AstraZeneca Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. AstraZeneca Inhaler Corticosteroid Device Product Offerings
    Table 91. AstraZeneca Recent Development
    Table 92. F. Hoffmann-La Roche Ltd. Company Information
    Table 93. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
    Table 94. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product Offerings
    Table 96. F. Hoffmann-La Roche Ltd. Recent Development
    Table 97. Amgen Inc. Company Information
    Table 98. Amgen Inc. Introduction and Business Overview
    Table 99. Amgen Inc. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Amgen Inc. Inhaler Corticosteroid Device Product Offerings
    Table 101. Amgen Inc. Recent Development
    Table 102. Aurobindo Pharma Company Information
    Table 103. Aurobindo Pharma Introduction and Business Overview
    Table 104. Aurobindo Pharma Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Aurobindo Pharma Inhaler Corticosteroid Device Product Offerings
    Table 106. Aurobindo Pharma Recent Development
    Table 107. Sumitomo Corporation Company Information
    Table 108. Sumitomo Corporation Introduction and Business Overview
    Table 109. Sumitomo Corporation Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Sumitomo Corporation Inhaler Corticosteroid Device Product Offerings
    Table 111. Sumitomo Corporation Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Inhaler Corticosteroid Device Downstream Customers
    Table 115. Inhaler Corticosteroid Device Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Inhaler Corticosteroid Device Product Picture
    Figure 2. Global Inhaler Corticosteroid Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Inhaler Corticosteroid Device Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Inhaler Corticosteroid Device Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Inhaler Corticosteroid Device Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Inhaler Corticosteroid Device Report Years Considered
    Figure 7. Global Inhaler Corticosteroid Device Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Inhaler Corticosteroid Device Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inhaler Corticosteroid Device Revenue in 2023
    Figure 10. Inhaler Corticosteroid Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Beclomethasone Dipropionate Picture
    Figure 12. Budesonide Picture
    Figure 13. Fluticasone Inhaler Powder Picture
    Figure 14. Mometasone Picture
    Figure 15. Global Inhaler Corticosteroid Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Inhaler Corticosteroid Device Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Inhaler Corticosteroid Device Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Inhaler Corticosteroid Device Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Inhaler Corticosteroid Device Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Hospitals and Clinics
    Figure 21. Product Picture of Academic and Research Institutes
    Figure 22. Global Inhaler Corticosteroid Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Inhaler Corticosteroid Device Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Inhaler Corticosteroid Device Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Inhaler Corticosteroid Device Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Inhaler Corticosteroid Device Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Inhaler Corticosteroid Device Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Inhaler Corticosteroid Device Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Inhaler Corticosteroid Device Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Inhaler Corticosteroid Device Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Inhaler Corticosteroid Device Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Inhaler Corticosteroid Device Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Inhaler Corticosteroid Device Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Inhaler Corticosteroid Device Sales Volume (%), (2019-2030)
    Figure 39. United States Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Inhaler Corticosteroid Device Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Inhaler Corticosteroid Device Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Inhaler Corticosteroid Device Sales Value by Application (%), 2023 VS 2030
    Figure 60. Inhaler Corticosteroid Device Industrial Chain
    Figure 61. Inhaler Corticosteroid Device Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS